The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients
Published date:
09/16/2021
Excerpt:
This study was conducted on 224 ER-positive breast cancer patients...group 1 was tamoxifen sensitive and groups 2 and 3 were tamoxifen resistant...SOX2 and AGR2 biomarkers expression and serum AGR2 level were significantly higher in groups 2 and 3 in comparison to group 1...